ABC | Volume 114, Nº1, Janeiro 2020

Artigo Original Adar et al. Calcificação da aorta e pressão arterial não-dipper Arq Bras Cardiol. 2020; 114(1):109-117 1. Tigen K, Karaahmet T, Fotbolcu H, Gurel E, Cevik C, Gecmen C, et al. The influence of dipper and nondipper blood pressure patterns on left ventricular functions in hypertensive patients: a tissueDoppler study. Turk Kardiyol Dem Ars. 2009;37(2):101-6. 2. Della Mea P, Lupia M, Bandolin V, Guzzon S, Sonino N, Vettor R, et al. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients.Am J Hypertes. 2005;18(1):30-5. 3. Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am j Hypertens. 1991;4(1 Pt 1):20-6. 4. Ozdemir E, Yildirimturk O, Cengiz B, Yurdakul S, Aytekin S. Evaluation of carotid intima-media thickness and aortic elasticity in patients with nondipper hypertension. Echocardiography. 2014;31(5):663-8. 5. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. NEngl J Med. 2003;348(24):2407-15. 6. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens. 1997;15(4):357-64. 7. Syrseloudis D, Tsioufis C, Andrikou I, Mazaraki A, Thomopoulos C, Mihas C, et al. Association of nighttime hypertension with central arterial stiffness and urinary albumin excretion in dipper hypertensive subjects. Hypertens Res. 2011;34(1):120-5. 8. Jerrard-Dunne P, Mahmud A, Feely J. Circadian blood pressure variation: relationship between dipper status and measures of arterial stiffness. J Hypertens. 2007;25(6):1233-9. 9. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapyofarterialstiffness.ArteriosclerThrombVascBiol.2005;25(5):932-43. 10. LondonGM,MarchaisSJ,GuerinAP,PannierB.Arterialstiffness:pathophysiology and clinical impact. Clin ExpHipertens. 2004;26(7-8):689-99. 11. Ozturk S, Baltaci D, Ayhan SS, Durmus I, Gedikli O, Soyturk M, et al. Assessment of the relationship between aortic pulsewave velocity and aortic arch calcification. Turk Kardiyol Dem Ars. 2012;40(8):683-9. 12. Sekikawa A, Shin C, Curb JD, Barinas-Mitchell E, Masaki K, El-Saed A, et al. Aortic stiffness and calcification inmen in a population-based international study. Atherosclerosis. 2012;222(2):473-7. 13. Symeonidis G, Papanas N, Giannakis I, Mavridis G, Lakasas G, Kyriakidis G, et al. Gravity of aortic arch calcification as evaluated in adult Greek patients. Int Angiol.2002;21(3):233-6. 14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann InternMed. 2009;150(9):604-12. 15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450-8. 16. ManciaG,FagardR,NarkiewiczK,Redon J,ZanchettiA,BohmM,etal.2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281-357. 17. Cuspidi C, Meani S, Valerio C, Esposito A, Sala C, Maisaidi M, et al. Ambulatory blood pressure, target organ damage and aortic root size in never-treated essential hypertensive patients. J Human Hypertens. 2007;21(7):531-8. 18. Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999;282(6):539-46. 19. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51(1):55-61. 20. Garcia-Ortiz L, Gomez-Marcos MA, Martin-Moreiras J, Gonzalez-Elena LJ, Recio-Rodriguez JI, Castano-Sanchez Y, et al. Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organdamage inhypertensivepatients (LOD-RISKstudy).BloodPressMonit. 2009;14(4):145-51. 21. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with andwithout high 24-h blood pressure: theOhasama study. J Hypertens.. 2002;20(11):2183-9. 22. Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU. Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently? Vasc Health Risk Manag. 2013;9:125-33. 23. Turgut AT, Sonmez I, Cakit BD, Kosar P, Kosar U. Pineal gland calcification, lumbar intervertebral disc degeneration and abdominal aorta calcifying atherosclerosis correlate in low back pain subjects: A cross-sectional observational CT study. Pathophysiology . 2008;15(1):31-9. 24. Arangino S, Cagnacci A, Angiolucci M, Vacca AM, Longu G, Volpe A, et al. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol. 1999;83(9):1417-9. 25. Pechanova O, Paulis L, Simko F. Peripheral and central effects of melatonin on blood pressure regulation. Int J Mol Sci. 2014;15(10):17920-37. 26. Ray CA. Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans. J Physiol. 2003;551(Pt 3):1043-8. 27. Shen A, Zheng D, Hu Z. [Associations of circadian blood pressure rhythm with autonomic nervous system and myocardial energy expenditure level in patients with primary hypertension]. Nan Fang Xi Ke Da Xue Xue Bao.2014;34(5):713-7. 28. Dauphinot V, Gosse P, Kossovsky MP, Schott AM, Rouch I, Pichot V, et al. Autonomic nervous system activity is independently associated with the risk of shift in the non-dipper blood pressure pattern. Hypertens Res. 2010;33(10):1032-7. 29. Dodt C, Breckling U, Derad I, Fehm HL, Born J. Plasma epinephrine and norepinephrine concentrations of healthy humans associatedwith nighttime sleep and morning arousal. Hypertension. 1997;30(1 Pt 1):71-6. 30. Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of alpha-adrenergic blocker, doxazosin : results from the HALT study. Hypertension. 2000;35(3):787-94. 31. Kozirog M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients withmetabolic syndrome. J Pineal Res, 2011;50(3):261-6. 32. MozdzanM, MozdzanM, Chalubinski M, Wojdan K, Broncel M. The effect of melatonin on circadian blood pressure in patients with type 2 diabetes and essential hypertension. Arch Med Sci. 2014;10(4):669-75. 33. Tsao CW, Pencina KM, Massaro JM, Benjamin EJ, Levy D, Vasan RS, et al. Cross-sectional relations of arterial stiffness, pressure pulsatility, wave reflection, and arterial calcification. Arterioscler Thromb Vasc Biol. 2014;14;34(11):2495-500. 34. Kuzeytemiz M, Karaagac K, Vatansever F, Ozluk OA, Yilmaz M, Arslan B, et al. Theeffectofnon-dipperanddipperbloodpressurepatternsonaorticelasticity inpatientswithmetabolicsyndrome.ClinExperHypertens.2013;35(8):632-6. Referências 116